Evaluation of IL-12 in immunotherapy and vaccine design in experimental mycobacterium avium infections

Journal of Immunology

Volumn 161, Issue 10, 1998, Pages 5578-5585

  Silva, Regina A ^a   Pais, Teresa F ^a   Appelberg, Rui ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM CHLORIDE; BACTERIAL PROTEIN; CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; MYCOBACTERIUM VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 12;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENTIATION; FEMALE; GENE DISRUPTION; IMMUNOCOMPETENCE; IMMUNOTHERAPY; INTERFERON PRODUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SPLEEN CELL; VACCINE PRODUCTION;

EID: 0032533852     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Cooper, A. M., A. D. Roberts, E. R. Rhoades, J. E. Callahan, D. M. Getzy, and I. M. Orme. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423.
2. Saunders, B. M., Y. Zhan, and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance of mice to Mycobacterium avium complex infection. Infect. Immun. 63:4011.
3. Mattner, F., J. Magram, J. Ferrante, P. Laumois, K. di Padova, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553.
4. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, P. Puccetti, S. F. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for Th type 1 differentiation in murine candidiasis. J. Immunol. 152:5167.
5. Zhan, Y., and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect. Immun. 63:1387.
6. Kincy-Cain, T., J. D. Clements, and K. L. Bost. 1996. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect. Immun. 64:1437.
7. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. J. Immunol. 152:1883.
8. Mastroeni, P., J. A. Harrison, J. A. Chabalgoity, and C. E. Hormaeche. 1996. Effect of interleukin 12 neutralization on host resistance and γ interferon production in mouse typhoid. Infect. Immun. 64:189.
9. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186:39.
10. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoptasma capsulation through induction of IFN-γ. J. Immunol. 155:785.
11. Urban, J. F., R. Fayer, S.-J. Chen, W. C. Cause, M. K. Gately, and F. D. Finkelman. 1996. IL-12 protects immunocompetent and immunodencient neonatal mice against infection with Cryptosporidium parvum. J. Immunol. 156: 263.
12. Murray, H. W., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387.
13. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburtth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
14. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
15. Khan, I. A., T. Matsuura, and L. H. Kasper. 1994. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62:1639.
16. Hunter, C. A., T. Slifer, and F. Araujo. 1996. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor α and γ interferon. Infect. Immun. 64:2381.
17. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of Interferon γ-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700.
18. Cooper, A. M., J. E. Callahan, J. P. Griffin, A. D. Roberts, and I. M. Orme. 1995. Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis. Infect. Immun. 63:3259.
19. Kobayashi, K., J. Yamazaki, T. Kasama, T. Katsura, K. Kasahara, S. F. Wolf, and T. Shimamura. 1996. Interleukin (IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy. J. Infect. Dis. 174:564.
20. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515.
21. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235.
22. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Caspar, F. A. Lewis, and A. Sher. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594.
23. Drysdale, P., D. A. Lammas, K. Quibell, D. S. Kumararatne, D. Schoell-Tollner, J. Girdlestone, M. Wadhwa, P. Dilger, H. Dockrell, K. Britten, and A. Segal. 1997. Studies on two patients with disseminated intracellular mycobacterial infections, one with defective IL-12 p40 production and the other with defective IL-12 receptor signalling. Immunology 92:80 (Abstr.).
24. Pozniak, A. L., A. H. C. Uttley, and R. J. Kent. 1996. Mycobacterium avium complex in AIDS: who, when, where, why, and how. Soc. Appl. Bacteriol. Symp. Ser. 81:405.
25. Horsburgh, CR. 1991. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324:1332.
26. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941.
27. Appelberg, R., A. G. Castro, J. Pedrosa, R. A. Silva, I. M. Orme, and P. Minóprio. 1994. The role of γ interferon and tumor necrosis factor-α during the T cell-independent and -dependent phases of Mycobacterium avium infection. Infect. Immun. 62:3962.
28. Castro, A. G., R. A. Silva, and R. Appelberg. 1995. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice. J. Immunol. 155:2013.
29. Dalton, D. K., S. Pins-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739.
30. Murphy, E., S. Hieny, A. Sher, and A. O'Garra. 1993. Detection of in vivo expression of interleukin-10 using a semiquantitative polymerase chain reaction method in Schistosoma mansoni-infected mice. J. Immunol. Methods 162:211.
31. Castro, A. G., P. Minoprio, and R. Appelberg. 1995. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice. Immunology 85:556.
32. Orme, I. M., P. Andersen, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481.
33. Lindblad, E., M. J. Elhay, R. Silva, R. Appelberg, and P. Andersen. 1997. Adjuvant modulation of immune responses to tuberculosis sub-unit vaccines. Infect. Immun. 65:623.
34. Toba, H., J. T. Crawford, and J. J. Ellner. 1989. Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of γ interferon. Infect. Immun. 57:239.
35. Douvas, G. S., D. L. Looker, A. E. Vatter, and A. J. Crowle. 1985. γ interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect. Immun. 50:1.
36. Pedrosa, J., M. Flórido, Z. M. Kunze, A. G. Castro, F. Portaels, J. J. McFadden, M. T. Silva, and R. Appelberg. 1994. Characterization of the virulence of Mycobacterium avium complex isolates in mice. Clin. Exp. Immunol. 98:210.
37. Orange, J. S., T. P. Salazar-Mather, S. M. Opal, R. L. Spencer, A. H. Miller, B. S. McEwen, and C. A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901.
38. Doherty, T. M., and A. Sher. 1998. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice. J. Immunol. 160:5428.